Meeting
2018 ASCO Annual Meeting
Liver-directed treatment for patients with uveal melanoma hepatic metastasis: A retrospective analysis of overall survival.
Authors
Rino S Seedor
Sidney Kimmel Medical College of Thomas Jefferson University, Philadelphia, PA
Rino S Seedor , David J. Eschelman , Carin F. Gonsalves , Robert D. Adamo , Marlana M. Orloff , Anjum Amjad , Erin Sharpe-Mills , Ryan Michael Weight , Allison Gradone , Carol L Shields , Jerry A Shields , Michael J. Mastrangelo , Takami Sato
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Local-Regional Disease
Citation
J Clin Oncol 36, 2018 (suppl; abstr 9592)
DOI
10.1200/JCO.2018.36.15_suppl.9592
Abstract #
9592
Poster Bd #
419
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Survival outcomes associated with liver-directed therapies in patients with metastatic uveal melanoma.
First Author: Michael M Caplan
Poster
2022 ASCO Annual Meeting
Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases, first results from a phase III randomized controlled multicenter trial (the SCANDIUM trial).
First Author: Roger Olofsson Bagge
Poster
2023 ASCO Annual Meeting
Survival after isolated hepatic perfusion as a treatment for uveal melanoma liver metastases: Results from a randomized controlled trial (the SCANDIUM trial).
First Author: Roger Olofsson Bagge
Poster
2023 ASCO Annual Meeting
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
First Author: Romain Cohen